Haemonetics

$116.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.65 (-0.55%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Haemonetics and other stocks, options, and ETFs commission-free!

About HAE

Haemonetics Corporation, also called Haemonetics, is a global healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate.

CEO

Christopher A. Simon

Employees

3,004

Headquarters

Boston, Massachusetts

Founded

1971

Market Cap

5.80B

Price-Earnings Ratio

55.22

Dividend Yield

—

Average Volume

503.69K

High Today

$119.71

Low Today

$116.81

Open Price

$119.09

Volume

130.70K

52 Week High

$142.11

52 Week Low

$74.48

Analyst Ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

HAE Earnings

$0.00

$0.31

$0.63

$0.94

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected May 4, Pre-Market